What type of study is this?

“Targeted Therapies and their Associated Molecular Alterations in the Treatment of Renal Cell Carcinoma”

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis highlights targeted therapies for renal cell carcinoma, suggesting genetic mutations drive treatment responses.

Targeted therapies improve outcomes for renal cell carcinoma patients, particularly those with ccRCC and VHL mutations.
Clear cell RCC (ccRCC) accounts for approximately 75% of cases, primarily driven by VHL gene mutations, impacting treatment effectiveness.
Histological analysis reveals clear cell cytology and strong vascularization in ccRCC, guiding targeted therapy decisions.
Loss of VHL gene function significantly contributes to tumor growth, indicating a critical therapeutic target in ccRCC management.

Priya Hays (2025) studied this question.

View Full Paper

Ask AI

Bookmark